25 XP   0   0   10

Epigral Ltd.
Buy, Hold or Sell?

Let's analyse Epigral together

PenkeI guess you are interested in Epigral Ltd.. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Epigral Ltd.. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Epigral Ltd.

I send you an email if I find something interesting about Epigral Ltd..

Quick analysis of Epigral (30 sec.)










What can you expect buying and holding a share of Epigral? (30 sec.)

How much money do you get?

How much money do you get?
INR0.28
When do you have the money?
1 year
How often do you get paid?
50.0%

What is your share worth?

Current worth
INR257.30
Expected worth in 1 year
INR587.63
How sure are you?
100.0%

+ What do you gain per year?

Total Gains per Share
INR353.65
Return On Investment
27.7%

For what price can you sell your share?

Current Price per Share
INR1,278.10
Expected price per share
INR931.60 - INR1,381
How sure are you?
50%

1. Valuation of Epigral (5 min.)




Live pricePrice per Share (EOD)

INR1,278.10

Intrinsic Value Per Share

INR133.23 - INR159.69

Total Value Per Share

INR390.53 - INR416.99

2. Growth of Epigral (5 min.)




Is Epigral growing?

Current yearPrevious yearGrowGrow %
How rich?$128.2m$87.1m$41.1m32.1%

How much money is Epigral making?

Current yearPrevious yearGrowGrow %
Making money$42.3m$30.3m$12m28.4%
Net Profit Margin16.1%16.3%--

How much money comes from the company's main activities?

3. Financial Health of Epigral (5 min.)




4. Comparing to competitors in the Chemicals industry (5 min.)




  Industry Rankings (Chemicals)  

What can you expect buying and holding a share of Epigral? (5 min.)

Welcome investor! Epigral's management wants to use your money to grow the business. In return you get a share of Epigral.

What can you expect buying and holding a share of Epigral?

First you should know what it really means to hold a share of Epigral. And how you can make/lose money.

Speculation

The Price per Share of Epigral is INR1,278. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Epigral.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Epigral, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is INR257.30. Based on the TTM, the Book Value Change Per Share is INR82.58 per quarter. Based on the YOY, the Book Value Change Per Share is INR57.63 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is INR5.83 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Epigral.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 INR% of Price per ShareINR% of Price per ShareINR% of Price per ShareINR% of Price per ShareINR% of Price per Share
Usd Eps1.020.1%1.020.1%0.730.1%0.550.0%0.550.0%
Usd Book Value Change Per Share0.990.1%0.990.1%0.690.1%0.770.1%0.770.1%
Usd Dividend Per Share0.070.0%0.070.0%0.000.0%0.030.0%0.030.0%
Usd Total Gains Per Share1.060.1%1.060.1%0.690.1%0.800.1%0.800.1%
Usd Price Per Share11.32-11.32-11.67-5.75-5.75-
Price to Earnings Ratio11.10-11.10-15.99-6.77-6.77-
Price-to-Total Gains Ratio10.67-10.67-16.88-13.78-13.78-
Price to Book Ratio3.67-3.67-5.57-2.31-2.31-
Price-to-Total Gains Ratio10.67-10.67-16.88-13.78-13.78-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share15.3372
Number of shares65
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.070.03
Usd Book Value Change Per Share0.990.77
Usd Total Gains Per Share1.060.80
Gains per Quarter (65 shares)68.9651.88
Gains per Year (65 shares)275.85207.51
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
1182582667201198
23651554214401406
35577381820602614
4731031109427803822
591128813703410031030
6109154616464112041238
7127180419224814051446
8146206121985516061654
9164231924746118061862
10182257727506820072070

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share1.00.00.0100.0%3.00.00.0100.0%4.00.00.0100.0%4.00.00.0100.0%4.00.00.0100.0%
Book Value Change Per Share1.00.00.0100.0%3.00.00.0100.0%4.00.00.0100.0%4.00.00.0100.0%4.00.00.0100.0%
Dividend per Share1.00.00.0100.0%1.00.02.033.3%2.00.02.050.0%2.00.02.050.0%2.00.02.050.0%
Total Gains per Share1.00.00.0100.0%3.00.00.0100.0%4.00.00.0100.0%4.00.00.0100.0%4.00.00.0100.0%

Fundamentals of Epigral

About Epigral Ltd.

Epigral Limited manufactures and sells chlor-alkali and related derivatives in India and internationally. The company offers chlorinated polyvinyl chloride (CPVC) resins, epichlorohydrin, chloromethanes, hydrogen peroxide, caustic soda, chlorine, hydrogen, and caustic potash products. It also trades in agrochemical products. The company serves various sectors, including CPVC pipes and fittings, windmills, construction, paints and coatings, electronics, water treatment, agrochemicals, pharmaceuticals, refineries, soap and detergents, fluoropolymers, paper and pulp, textiles, alumina, polyurethane foam, lithium, and polytetrafluoroethylene (PTFE) pipes. The company was formerly known as Meghmani Finechem Limited and changed its name to Epigral Limited in August 2023. Epigral Limited was incorporated in 2007 and is based in Ahmedabad, India.

Fundamental data was last updated by Penke on 2024-04-23 21:15:05.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge profit.
Using its assets, the company is efficient in making profit.
Using its investors money, the company is very efficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very efficient.
The company is efficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is unable to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is able to pay all its debts by selling its assets.
The company is able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is fair priced.
Based on the earnings, the company is underpriced.
Based on how much money comes from the company's main activities, the company is underpriced.

1.1. Profitability of Epigral Ltd..

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Epigral earns for each ₹1 of revenue.

  • Above 10% is considered healthy but always compare Epigral to the Chemicals industry mean.
  • A Net Profit Margin of 16.1% means that ₹0.16 for each ₹1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Epigral Ltd.:

  • The MRQ is 16.1%. The company is making a huge profit. +2
  • The TTM is 16.1%. The company is making a huge profit. +2
Trends
Current periodCompared to+/- 
MRQ16.1%TTM16.1%0.0%
TTM16.1%YOY16.3%-0.2%
TTM16.1%5Y15.8%+0.4%
5Y15.8%10Y15.8%0.0%
Compared to industry (Chemicals)
PeriodCompanyIndustry (mean)+/- 
MRQ16.1%3.6%+12.5%
TTM16.1%3.6%+12.5%
YOY16.3%6.3%+10.0%
5Y15.8%5.2%+10.6%
10Y15.8%5.5%+10.3%
1.1.2. Return on Assets

Shows how efficient Epigral is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Epigral to the Chemicals industry mean.
  • 14.5% Return on Assets means that Epigral generated ₹0.15 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Epigral Ltd.:

  • The MRQ is 14.5%. Using its assets, the company is efficient in making profit. +1
  • The TTM is 14.5%. Using its assets, the company is efficient in making profit. +1
Trends
Current periodCompared to+/- 
MRQ14.5%TTM14.5%0.0%
TTM14.5%YOY11.9%+2.6%
TTM14.5%5Y10.5%+4.0%
5Y10.5%10Y10.5%0.0%
Compared to industry (Chemicals)
PeriodCompanyIndustry (mean)+/- 
MRQ14.5%0.7%+13.8%
TTM14.5%0.9%+13.6%
YOY11.9%1.6%+10.3%
5Y10.5%1.3%+9.2%
10Y10.5%1.4%+9.1%
1.1.3. Return on Equity

Shows how efficient Epigral is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Epigral to the Chemicals industry mean.
  • 33.0% Return on Equity means Epigral generated ₹0.33 for each ₹1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Epigral Ltd.:

  • The MRQ is 33.0%. Using its investors money, the company is very efficient in making profit. +2
  • The TTM is 33.0%. Using its investors money, the company is very efficient in making profit. +2
Trends
Current periodCompared to+/- 
MRQ33.0%TTM33.0%0.0%
TTM33.0%YOY34.8%-1.8%
TTM33.0%5Y25.5%+7.6%
5Y25.5%10Y25.5%0.0%
Compared to industry (Chemicals)
PeriodCompanyIndustry (mean)+/- 
MRQ33.0%1.4%+31.6%
TTM33.0%1.7%+31.3%
YOY34.8%2.9%+31.9%
5Y25.5%2.5%+23.0%
10Y25.5%2.5%+23.0%

1.2. Operating Efficiency of Epigral Ltd..

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Epigral is operating .

  • Measures how much profit Epigral makes for each ₹1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Epigral to the Chemicals industry mean.
  • An Operating Margin of 26.9% means the company generated ₹0.27  for each ₹1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Epigral Ltd.:

  • The MRQ is 26.9%. The company is operating very efficient. +2
  • The TTM is 26.9%. The company is operating very efficient. +2
Trends
Current periodCompared to+/- 
MRQ26.9%TTM26.9%0.0%
TTM26.9%YOY26.7%+0.1%
TTM26.9%5Y24.8%+2.0%
5Y24.8%10Y24.8%0.0%
Compared to industry (Chemicals)
PeriodCompanyIndustry (mean)+/- 
MRQ26.9%7.6%+19.3%
TTM26.9%2.5%+24.4%
YOY26.7%7.8%+18.9%
5Y24.8%7.2%+17.6%
10Y24.8%6.5%+18.3%
1.2.2. Operating Ratio

Measures how efficient Epigral is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Chemicals industry mean).
  • An Operation Ratio of 0.73 means that the operating costs are ₹0.73 for each ₹1 in net sales.

Let's take a look of the Operating Ratio trends of Epigral Ltd.:

  • The MRQ is 0.735. The company is efficient in keeping operating costs low. +1
  • The TTM is 0.735. The company is efficient in keeping operating costs low. +1
Trends
Current periodCompared to+/- 
MRQ0.735TTM0.7350.000
TTM0.735YOY0.727+0.008
TTM0.7355Y0.746-0.012
5Y0.74610Y0.7460.000
Compared to industry (Chemicals)
PeriodCompanyIndustry (mean)+/- 
MRQ0.7351.722-0.987
TTM0.7351.709-0.974
YOY0.7271.618-0.891
5Y0.7461.641-0.895
10Y0.7461.362-0.616

1.3. Liquidity of Epigral Ltd..

1.3. Liquidity
1.3.1. Current Ratio

Measures if Epigral is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Chemicals industry mean).
  • A Current Ratio of 0.65 means the company has ₹0.65 in assets for each ₹1 in short-term debts.

Let's take a look of the Current Ratio trends of Epigral Ltd.:

  • The MRQ is 0.648. The company is unable to pay all its short-term debts. -2
  • The TTM is 0.648. The company is unable to pay all its short-term debts. -2
Trends
Current periodCompared to+/- 
MRQ0.648TTM0.6480.000
TTM0.648YOY0.840-0.192
TTM0.6485Y0.613+0.035
5Y0.61310Y0.6130.000
Compared to industry (Chemicals)
PeriodCompanyIndustry (mean)+/- 
MRQ0.6481.622-0.974
TTM0.6481.640-0.992
YOY0.8401.655-0.815
5Y0.6131.793-1.180
10Y0.6131.458-0.845
1.3.2. Quick Ratio

Measures if Epigral is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Epigral to the Chemicals industry mean.
  • A Quick Ratio of 0.34 means the company can pay off ₹0.34 for each ₹1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Epigral Ltd.:

  • The MRQ is 0.338. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.338. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.338TTM0.3380.000
TTM0.338YOY0.536-0.198
TTM0.3385Y0.375-0.037
5Y0.37510Y0.3750.000
Compared to industry (Chemicals)
PeriodCompanyIndustry (mean)+/- 
MRQ0.3380.537-0.199
TTM0.3380.584-0.246
YOY0.5360.695-0.159
5Y0.3750.731-0.356
10Y0.3750.735-0.360

1.4. Solvency of Epigral Ltd..

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Epigral assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Epigral to Chemicals industry mean.
  • A Debt to Asset Ratio of 0.56 means that Epigral assets are financed with 56.0% credit (debt) and the remaining percentage (100% - 56.0%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Epigral Ltd.:

  • The MRQ is 0.560. The company is able to pay all its debts by selling its assets. +1
  • The TTM is 0.560. The company is able to pay all its debts by selling its assets. +1
Trends
Current periodCompared to+/- 
MRQ0.560TTM0.5600.000
TTM0.560YOY0.658-0.098
TTM0.5605Y0.572-0.012
5Y0.57210Y0.5720.000
Compared to industry (Chemicals)
PeriodCompanyIndustry (mean)+/- 
MRQ0.5600.426+0.134
TTM0.5600.420+0.140
YOY0.6580.427+0.231
5Y0.5720.412+0.160
10Y0.5720.420+0.152
1.4.2. Debt to Equity Ratio

Measures if Epigral is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Epigral to the Chemicals industry mean.
  • A Debt to Equity ratio of 127.5% means that company has ₹1.28 debt for each ₹1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Epigral Ltd.:

  • The MRQ is 1.275. The company is able to pay all its debts with equity. +1
  • The TTM is 1.275. The company is able to pay all its debts with equity. +1
Trends
Current periodCompared to+/- 
MRQ1.275TTM1.2750.000
TTM1.275YOY1.925-0.650
TTM1.2755Y1.375-0.100
5Y1.37510Y1.3750.000
Compared to industry (Chemicals)
PeriodCompanyIndustry (mean)+/- 
MRQ1.2750.780+0.495
TTM1.2750.759+0.516
YOY1.9250.766+1.159
5Y1.3750.758+0.617
10Y1.3750.817+0.558

2. Market Valuation of Epigral Ltd.

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ₹1 in earnings Epigral generates.

  • Above 15 is considered overpriced but always compare Epigral to the Chemicals industry mean.
  • A PE ratio of 11.10 means the investor is paying ₹11.10 for every ₹1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Epigral Ltd.:

  • The EOD is 15.032. Based on the earnings, the company is fair priced.
  • The MRQ is 11.098. Based on the earnings, the company is underpriced. +1
  • The TTM is 11.098. Based on the earnings, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD15.032MRQ11.098+3.933
MRQ11.098TTM11.0980.000
TTM11.098YOY15.990-4.892
TTM11.0985Y6.772+4.326
5Y6.77210Y6.7720.000
Compared to industry (Chemicals)
PeriodCompanyIndustry (mean)+/- 
EOD15.03210.075+4.957
MRQ11.09810.287+0.811
TTM11.09812.008-0.910
YOY15.99011.444+4.546
5Y6.77215.970-9.198
10Y6.77222.435-15.663
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Epigral Ltd.:

  • The EOD is 25.324. Based on how much money comes from the company's main activities, the company is underpriced. +1
  • The MRQ is 18.697. Based on how much money comes from the company's main activities, the company is underpriced. +1
  • The TTM is 18.697. Based on how much money comes from the company's main activities, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD25.324MRQ18.697+6.627
MRQ18.697TTM18.6970.000
TTM18.697YOY-23.434+42.131
TTM18.6975Y-1.184+19.881
5Y-1.18410Y-1.1840.000
Compared to industry (Chemicals)
PeriodCompanyIndustry (mean)+/- 
EOD25.3240.634+24.690
MRQ18.6970.754+17.943
TTM18.6970.768+17.929
YOY-23.4341.389-24.823
5Y-1.1841.730-2.914
10Y-1.1842.023-3.207
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Epigral is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Chemicals industry mean).
  • A PB ratio of 3.67 means the investor is paying ₹3.67 for each ₹1 in book value.

Let's take a look of the Price to Book Ratio trends of Epigral Ltd.:

  • The EOD is 4.967. Based on the equity, the company is fair priced.
  • The MRQ is 3.667. Based on the equity, the company is fair priced.
  • The TTM is 3.667. Based on the equity, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD4.967MRQ3.667+1.300
MRQ3.667TTM3.6670.000
TTM3.667YOY5.568-1.900
TTM3.6675Y2.309+1.359
5Y2.30910Y2.3090.000
Compared to industry (Chemicals)
PeriodCompanyIndustry (mean)+/- 
EOD4.9671.378+3.589
MRQ3.6671.378+2.289
TTM3.6671.527+2.140
YOY5.5681.805+3.763
5Y2.3091.704+0.605
10Y2.3092.021+0.288
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Epigral Ltd. compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--82.58282.5820%57.628+43%64.326+28%64.326+28%
Book Value Per Share--257.304257.3040%174.721+47%162.400+58%162.400+58%
Current Ratio--0.6480.6480%0.840-23%0.613+6%0.613+6%
Debt To Asset Ratio--0.5600.5600%0.658-15%0.572-2%0.572-2%
Debt To Equity Ratio--1.2751.2750%1.925-34%1.375-7%1.375-7%
Dividend Per Share--5.8305.8300%-+100%2.184+167%2.184+167%
Eps--85.02785.0270%60.839+40%45.603+86%45.603+86%
Free Cash Flow Per Share--50.47150.4710%-41.512+182%-5.181+110%-5.181+110%
Free Cash Flow To Equity Per Share--2.3872.3870%5.471-56%-3.833+261%-3.833+261%
Gross Profit Margin--1.0001.0000%0.933+7%0.962+4%0.962+4%
Intrinsic Value_10Y_max--159.690--------
Intrinsic Value_10Y_min--133.226--------
Intrinsic Value_1Y_max--7.259--------
Intrinsic Value_1Y_min--7.054--------
Intrinsic Value_3Y_max--28.475--------
Intrinsic Value_3Y_min--26.773--------
Intrinsic Value_5Y_max--57.723--------
Intrinsic Value_5Y_min--52.456--------
Market Cap--39208806596.70039208806596.7000%40419993702.400-3%19907200074.775+97%19907200074.775+97%
Net Profit Margin--0.1610.1610%0.163-1%0.158+2%0.158+2%
Operating Margin--0.2690.2690%0.267+0%0.248+8%0.248+8%
Operating Ratio--0.7350.7350%0.727+1%0.746-2%0.746-2%
Pb Ratio4.967+26%3.6673.6670%5.568-34%2.309+59%2.309+59%
Pe Ratio15.032+26%11.09811.0980%15.990-31%6.772+64%6.772+64%
Price Per Share1278.100+26%943.650943.6500%972.800-3%479.113+97%479.113+97%
Price To Free Cash Flow Ratio25.324+26%18.69718.6970%-23.434+225%-1.184+106%-1.184+106%
Price To Total Gains Ratio14.456+26%10.67310.6730%16.881-37%13.777-23%13.777-23%
Quick Ratio--0.3380.3380%0.536-37%0.375-10%0.375-10%
Return On Assets--0.1450.1450%0.119+22%0.105+38%0.105+38%
Return On Equity--0.3300.3300%0.348-5%0.255+30%0.255+30%
Total Gains Per Share--88.41288.4120%57.628+53%66.510+33%66.510+33%
Usd Book Value--128292024.000128292024.0000%87116340.000+47%91880226.000+40%91880226.000+40%
Usd Book Value Change Per Share--0.9910.9910%0.692+43%0.772+28%0.772+28%
Usd Book Value Per Share--3.0883.0880%2.097+47%1.949+58%1.949+58%
Usd Dividend Per Share--0.0700.0700%-+100%0.026+167%0.026+167%
Usd Eps--1.0201.0200%0.730+40%0.547+86%0.547+86%
Usd Free Cash Flow--25164876.00025164876.0000%-20697900.000+182%-4048068.000+116%-4048068.000+116%
Usd Free Cash Flow Per Share--0.6060.6060%-0.498+182%-0.062+110%-0.062+110%
Usd Free Cash Flow To Equity Per Share--0.0290.0290%0.066-56%-0.046+261%-0.046+261%
Usd Market Cap--470505679.160470505679.1600%485039924.429-3%238886400.897+97%238886400.897+97%
Usd Price Per Share15.337+26%11.32411.3240%11.674-3%5.749+97%5.749+97%
Usd Profit--42394872.00042394872.0000%30334416.000+40%24567423.000+73%24567423.000+73%
Usd Revenue--262607964.000262607964.0000%185967984.000+41%155227269.000+69%155227269.000+69%
Usd Total Gains Per Share--1.0611.0610%0.692+53%0.798+33%0.798+33%
 EOD+2 -4MRQTTM+0 -0YOY+24 -125Y+30 -610Y+30 -6

3.2. Fundamental Score

Let's check the fundamental score of Epigral Ltd. based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1515.032
Price to Book Ratio (EOD)Between0-14.967
Net Profit Margin (MRQ)Greater than00.161
Operating Margin (MRQ)Greater than00.269
Quick Ratio (MRQ)Greater than10.338
Current Ratio (MRQ)Greater than10.648
Debt to Asset Ratio (MRQ)Less than10.560
Debt to Equity Ratio (MRQ)Less than11.275
Return on Equity (MRQ)Greater than0.150.330
Return on Assets (MRQ)Greater than0.050.145
Total5/10 (50.0%)

3.3. Technical Score

Let's check the technical score of Epigral Ltd. based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5050.260
Ma 20Greater thanMa 501,315.593
Ma 50Greater thanMa 1001,220.136
Ma 100Greater thanMa 2001,111.790
OpenGreater thanClose1,260.000
Total4/5 (80.0%)



Latest Balance Sheet

Balance Sheet of 2023-03-31. All numbers in thousands.

Summary
Total Assets24,322,353
Total Liabilities13,631,351
Total Stockholder Equity10,691,002
 As reported
Total Liabilities 13,631,351
Total Stockholder Equity+ 10,691,002
Total Assets = 24,322,353

Assets

Total Assets24,322,353
Total Current Assets4,194,993
Long-term Assets20,127,360
Total Current Assets
Cash And Cash Equivalents 142,400
Short-term Investments 191,143
Net Receivables 1,664,670
Inventory 2,118,282
Other Current Assets 78,498
Total Current Assets  (as reported)4,194,993
Total Current Assets  (calculated)4,194,993
+/-0
Long-term Assets
Property Plant Equipment 19,369,577
Long-term Assets Other 162,348
Long-term Assets  (as reported)20,127,360
Long-term Assets  (calculated)19,531,925
+/- 595,435

Liabilities & Shareholders' Equity

Total Current Liabilities6,476,905
Long-term Liabilities7,154,446
Total Stockholder Equity10,691,002
Total Current Liabilities
Short-term Debt 3,327,727
Accounts payable 1,101,730
Other Current Liabilities 117,539
Total Current Liabilities  (as reported)6,476,905
Total Current Liabilities  (calculated)4,546,996
+/- 1,929,909
Long-term Liabilities
Long-term Liabilities  (as reported)7,154,446
Long-term Liabilities  (calculated)0
+/- 7,154,446
Total Stockholder Equity
Common Stock415,502
Retained Earnings 12,742,300
Accumulated Other Comprehensive Income -2,466,800
Total Stockholder Equity (as reported)10,691,002
Total Stockholder Equity (calculated)10,691,002
+/-0
Other
Cash and Short Term Investments 333,543
Common Stock Shares Outstanding 41,550
Current Deferred Revenue1,929,909
Liabilities and Stockholders Equity 24,322,353
Net Debt 8,645,222
Net Working Capital -2,281,912
Short Long Term Debt Total 8,787,622



Balance Sheet

All numbers in thousands.

 Trend2023-03-312022-03-312021-03-312020-03-31
> Total Assets 
12,734,618
14,487,021
21,236,662
24,322,353
24,322,35321,236,66214,487,02112,734,618
   > Total Current Assets 
1,320,826
1,812,918
4,469,442
4,194,993
4,194,9934,469,4421,812,9181,320,826
       Cash And Cash Equivalents 
969
6,800
250,854
142,400
142,400250,8546,800969
       Short-term Investments 
0
0
18,769
191,143
191,14318,76900
       Net Receivables 
835,822
1,196,170
2,584,278
1,664,670
1,664,6702,584,2781,196,170835,822
       Inventory 
484,031
539,597
1,541,389
2,118,282
2,118,2821,541,389539,597484,031
       Other Current Assets 
4
42,978
92,921
78,498
78,49892,92142,9784
   > Long-term Assets 
11,413,792
12,674,103
16,767,220
20,127,360
20,127,36016,767,22012,674,10311,413,792
       Property Plant Equipment 
11,341,762
12,223,305
16,366,439
19,369,577
19,369,57716,366,43912,223,30511,341,762
       Intangible Assets 
0
316,591
284,267
0
0284,267316,5910
       Long-term Assets Other 
62,517
-871,094
100
162,348
162,348100-871,09462,517
> Total Liabilities 
6,899,912
7,645,682
13,976,967
13,631,351
13,631,35113,976,9677,645,6826,899,912
   > Total Current Liabilities 
2,648,194
3,886,070
5,322,900
6,476,905
6,476,9055,322,9003,886,0702,648,194
       Short-term Debt 
1,085,596
1,985,395
2,223,618
3,327,727
3,327,7272,223,6181,985,3951,085,596
       Accounts payable 
467,924
730,493
881,050
1,101,730
1,101,730881,050730,493467,924
       Other Current Liabilities 
1,091,800
1,161,631
260,633
117,539
117,539260,6331,161,6311,091,800
   > Long-term Liabilities 
4,251,718
3,759,612
8,654,067
7,154,446
7,154,4468,654,0673,759,6124,251,718
> Total Stockholder Equity
5,834,706
6,841,339
7,259,695
10,691,002
10,691,0027,259,6956,841,3395,834,706
   Common Stock
415,527
415,527
415,502
415,502
415,502415,502415,527415,527
   Retained Earnings 
5,776,808
6,783,441
9,310,993
12,742,300
12,742,3009,310,9936,783,4415,776,808
   Capital Surplus 0000
   Treasury Stock0000
   Other Stockholders Equity 
-3,595
-2,466,828
-2,466,800
10,275,500
10,275,500-2,466,800-2,466,828-3,595



Balance Sheet

All numbers in thousands.




Cash Flow

All numbers in thousands.




Income Statement

All numbers in thousands.


Latest Income Statement (annual, 2023-03-31)

Gross Profit (+$)
totalRevenue21,883,997
Cost of Revenue-11,147,830
Gross Profit10,736,16710,736,167
 
Operating Income (+$)
Gross Profit10,736,167
Operating Expense-4,936,226
Operating Income5,879,6115,799,941
 
Operating Expense (+$)
Research Development0
Selling General Administrative0
Selling And Marketing Expenses0
Operating Expense4,936,2260
 
Net Interest Income (+$)
Interest Income0
Interest Expense-655,022
Other Finance Cost-655,022
Net Interest Income0
 
Pretax Income (+$)
Operating Income5,879,611
Net Interest Income0
Other Non-Operating Income Expenses0
Income Before Tax (EBT)5,224,5896,534,633
EBIT - interestExpense = 5,224,589
5,224,589
4,187,928
Interest Expense655,022
Earnings Before Interest and Taxes (EBIT)5,879,6115,879,611
Earnings Before Interest and Taxes (EBITDA)6,969,144
 
After tax Income (+$)
Income Before Tax5,224,589
Tax Provision-0
Net Income From Continuing Ops05,224,589
Net Income3,532,906
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses16,084,056
Total Other Income/Expenses Net-655,0220
 

Technical Analysis of Epigral
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Epigral. The general trend of Epigral is BULLISH with 71.4% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Epigral's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (71.4%) Bearish trend (-71.4%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Epigral Ltd..

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 1,380 < 1,381 < 1,381.

The bearish price targets are: 950.25 > 948.00 > 931.60.

Tweet this
Epigral Ltd. Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Epigral Ltd.. The current mas is .

The long score for the Moving Averages is 12/14.
The longshort score for the Moving Averages is 10/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Epigral Ltd. Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Epigral Ltd.. The current macd is 18.44.

The long score for the Moving Average Convergence/Divergence (MACD) is 1/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -2/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Epigral price going down in the near term. -2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Epigral. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Epigral price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Epigral Ltd. Daily Moving Average Convergence/Divergence (MACD) ChartEpigral Ltd. Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Epigral Ltd.. The current adx is 26.55.

The long score for the Directional Movement Index (DMI) is 3/7.
The longshort score for the Directional Movement Index (DMI) is 3/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Epigral shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX > 25 && ADX trending down: The ADX is above 25 and indicates a strong bullish trend. The ADX is declining, the bullish trend is weakening. Could be a potential reversal to the downside. +2
Epigral Ltd. Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Epigral Ltd.. The current sar is 1,410.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Epigral Ltd. Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Epigral Ltd.. The current rsi is 50.26. The current phase is Continuation in bull market.

The long score for the Relative Strength Index (RSI) is 4/13.
The longshort score for the Relative Strength Index (RSI) is 4/(-13 +13).

  • Continuation in bull market: Uptrend continues after a consolidation or pullback. Hold or add to existing positions.
  • Trending up: The RSI is trending up. +1
Epigral Ltd. Daily Relative Strength Index (RSI) ChartEpigral Ltd. Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Epigral Ltd.. The current phase is Oversold in bull market.

The long score for the Stochastic Oscillator is 3/6.
The longshort score for the Stochastic Oscillator is 0/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Epigral price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Epigral Ltd. Daily Stochastic Oscillator ChartEpigral Ltd. Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Epigral Ltd.. The current cci is -134.50469555.

The long score for the Commodity Channel Index (CCI) is 0/1.
The longshort score for the Commodity Channel Index (CCI) is -1/(-1 +1).

  • CCI < -100: The CCI is below -100, it indicates that the price is significantly below its average, suggesting a potential oversold condition. -1
Epigral Ltd. Daily Commodity Channel Index (CCI) ChartEpigral Ltd. Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Epigral Ltd.. The current cmo is -10.30847914.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Epigral Ltd. Daily Chande Momentum Oscillator (CMO) ChartEpigral Ltd. Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Epigral Ltd.. The current willr is -82.26650062.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is -1/(-1 +1).

  • WILLR < -80: The Williams %R is below -80. This indicates that the price is in oversold territory, suggesting a potential price correction or trend reversal to the upside. -1
Epigral Ltd. Daily Williams %R ChartEpigral Ltd. Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Epigral Ltd..

Epigral Ltd. Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Epigral Ltd.. The current atr is 55.25.

Epigral Ltd. Daily Average True Range (ATR) ChartEpigral Ltd. Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Epigral Ltd.. The current obv is 8,931,098.

Epigral Ltd. Daily On-Balance Volume (OBV) ChartEpigral Ltd. Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Epigral Ltd.. The current mfi is 58.80.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Epigral Ltd. Daily Money Flow Index (MFI) ChartEpigral Ltd. Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Epigral Ltd..

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-12-14STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-15STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-19SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-20MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-21DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-12-22DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-26MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-27CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2023-12-28SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-01-01STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-02STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-03STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-01-05RSI SHORT ENTRY LONG CLOSE70 crossover to downside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-01-09STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-10MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-01-11STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-15SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-01-16MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-01-19CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-20CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-22CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-23DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-01-24STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-29SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-31DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-01MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-02-02MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-05CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-07STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-09CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-12STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-15CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-16MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-19SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-20ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-21STOCH LONG EXITThe %K line crosses below the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-02-22STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-23STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-26STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-27STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-28RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2024-03-04STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-06MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-11DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-12ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-03-13CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-03-14STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-22DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-03-26CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-28MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-04-01WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-02CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-04-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-09RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2024-04-10STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-12STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-15SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-04-19STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-22SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-23STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-24MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-04-25MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-04-30STOCH SHORT EXITThe %K line crosses above the %D line.
2024-05-02STOCH LONG EXITThe %K line crosses below the %D line.
2024-05-03SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-05-06WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-05-08CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-05-09BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-05-10STOCH SHORT EXITThe %K line crosses above the %D line.

6.3. Candlestick Patterns

Epigral Ltd. Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Epigral Ltd. based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5050.260
Ma 20Greater thanMa 501,315.593
Ma 50Greater thanMa 1001,220.136
Ma 100Greater thanMa 2001,111.790
OpenGreater thanClose1,260.000
Total4/5 (80.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Epigral with someone you think should read this too:
  • Are you bullish or bearish on Epigral? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Epigral? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Epigral Ltd.

I send you an email if I find something interesting about Epigral Ltd..


Comments

How you think about this?

Leave a comment

Stay informed about Epigral Ltd..

Receive notifications about Epigral Ltd. in your mailbox!